{"schema_version":"secwatch.filing_event.v1","accession":"0001001250-24-000112","form_type":"8-K","ticker":"EL","cik":"0001001250","company_name":"ESTEE LAUDER COMPANIES INC","filed_at":"2024-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.830622+00:00","generated_at":"2026-05-31T08:37:22.870949+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Estée Lauder FY24 sales -2%, adj EPS -25%; Q4 organic sales +8%; FY25 cautious on China","bullets":["FY24 net sales $15.61B (-2% reported, -2% organic); GAAP EPS $1.08 (-61% YoY), adj EPS $2.59 (-25% YoY).","Q4 organic sales +8% to $3.87B; adjusted operating income $349M vs $71M prior year.","Skin Care -3% for FY24 but Q4 +15% organic; Fragrance +2% FY24; Hair Care -4%.","Completed DECIEM acquisition for $859M; Dr.Jart+ goodwill impairment $471M.","FY25 outlook: expects improved performance across most areas but continued softness in China."],"urls":{"canonical":"https://secwatch.observer/filing/0001001250-24-000112","json":"https://secwatch.observer/filing/0001001250-24-000112.json","markdown":"https://secwatch.observer/filing/0001001250-24-000112.md","text":"https://secwatch.observer/filing/0001001250-24-000112.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001250/000100125024000112/0001001250-24-000112-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001250/000100125024000112/el-20240819.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:37:22.870949+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}